Comparative effectiveness of Gliclazide MR and Sitagliptin

A comparative real-world study evaluating the effectiveness of Gliclazide Modified Release (MR) versus Sitagliptin as add-on therapy to metformin in patients with uncontrolled Type 2 diabetes. The study demonstrated that Gliclazide MR achieved superior glycemic control and a higher likelihood of reaching HbA1c targets compared with Sitagliptin, supporting its role as an effective second-line treatment option.